Рифат Сафади

Должность: Гепатолог
Языки: Английский, Иврит
Принимает: только взрослых



Профессор Рифат Сафади

Образование

Родился 24-го января 1965 года. Выпускник Еврейского университета (1999 г). Проходил ординатуру в отделении общей терапии а затем при отделении гастроэнтерологии университетской клиники "Хадасса".

Специализация

Заведующий центром гепатологии.

Профессиональная деятельность

Член комитета по развитию центра трансплантации соматических клеток Старший врач в отделении лечения заболеваний печени Член Американской и Европейской ассоциаций по изучению печени Автор многочисленных научных публикаций.

Научные публикации

A pH-Dependent Phase Separation Drives Polyamine-Mediated Silicification from Undersaturated Solutions
HCC TRANSPLANT CANDIDATES' SURVIVAL ON THE WAITING LIST - CAN ORGAN UTILIZATION BE IMPROVED?
Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis
Targeting CCL24 in Inflammatory and Fibrotic Diseases: Rationale and Results from Three CM-101 Phase 1 Studies
Low ALT Is Associated with IBD and Disease Activity: Results from a Nationwide Study
The liver in Greco-Arabic and Islamic medicine
TEN-HOUR INTERMITTENT FASTING PLUS MEDITERRANEAN DIET VERSUS MEDITERRANEAN DIET ALONE FOR TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories
The Lymphatic Endothelial Cell Secretome Inhibits Osteoblast Differentiation and Bone Formation
Weaker SARS-CoV-2 vaccine responses in nonalcoholic fatty liver disease with advanced liver fibrosis
Patients with low ALT levels are at increased risk for severe COVID-19
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study
CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis
The impact of obesity on postoperative complications and short-term survival after liver transplantation
Alleviation of Hepatic Steatosis by Alpha-Defensin Is Associated with Enhanced Lipolysis
Cardiorenal syndrome in the pediatric population: A systematic review
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries
Missed Nursing Care in Medical and Surgical Wards in Jordan: A Cross-Sectional Study
SARS-CoV-2 vaccine alleviates disease burden and severity in liver transplant recipients even with low antibody titers
Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib Treatment: A Real-World Study
Effect of Age on Liver Transplantation Recipient Outcomes: Two Centers' Experience
Pulmonary embolism risk in hospitalized patients with nonalcoholic fatty liver disease: A case-control study
Editorial: Fighting fire with fire: Using non-pathogenic viruses to control unrelated infections
Postpartum depression among first-time Jordanian mothers: levels and associated factors
Combined hepatocellular-cholangiocarcinoma derives from liver progenitor cells and depends on senescence and IL-6 trans-signaling
Streptococcus agalactiae imports spermidine by a member of the amino acid/polyamine antiporter family to endure citric acid stress at the vaginal pH
Sequential Combination of a Strong Interferon Inducer Viral Vector With Low Doses of Nivolumab Plus Ipilimumab Could Provide Functional Cure in Chronic Hepatitis B Virus infections: Technical Report Proposing a New Modality
Pharmacokinetics/pharmacodynamics of L-ornithine phenylacetate in overt hepatic encephalopathy and the effect of plasma ammonia concentration reduction on clinical outcomes
The Association Between Proton Pump Inhibitors and COVID-19 is Confounded by Hyperglycemia in a Population-Based Study
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
Advanced Liver Fibrosis Correlates With Impaired Efficacy of Pfizer-BioNTech COVID-19 Vaccine in Medical Employees
The Lived Experience of Critically-Ill Muslim Patients in Isolation
Editorial: targeting aberrant hepatic inflammation for treatment of non-alcoholic steatohepatitis-authors' reply
Nitric Oxide Induced stx2 Expression Is Inhibited by the Nitric Oxide Reductase, NorV, in a Clade 8 Escherichia coli O157:H7 Outbreak Strain
Fears and uncertainties of expectant mothers during the COVID-19 pandemic: trying to reclaim control
Genetic analysis of four consanguineous multiplex families with inflammatory bowel disease
Investigation of the polyamine biosynthetic and transport capability of Streptococcus agalactiae: the non-essential PotABCD transporter
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study
Randomised clinical trial: A phase 2 double-blind study of namodenoson in non-alcoholic fatty liver disease and steatohepatitis
Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
Parents' Experience of Having an Infant in the Neonatal Intensive Care Unit: A Qualitative Study
Kidney involvement in multisystem inflammatory syndrome in children: a pediatric nephrologist's perspective
Neurotransmitters and Neuropeptides decrease PD-1 in T cells of healthy subjects and patients with hepatocellular carcinoma (HCC), and increase their proliferation and eradication of HCC cells
Both high and low pre-infection glucose levels associated with increased risk for severe COVID-19: New insights from a population-based study
Sodium+/taurocholate cotransporting polypeptide as target therapy for liver fibrosis
Utility of open remote access medical advice in the COVID-19 pandemic among liver pre- and post-transplant patients
Multiple Roles of IL6 in Hepatic Injury, Steatosis, and Senescence Aggregate to Suppress Tumorigenesis
Показать ещё 42 статьи Скрыть статьи
Заболевания
Гепатит С
Рак печени
Первичный билиарный холангит
Острая печеночная порфирия
Процедуры
Трансплантация печени
Биопсия печени
Остались вопросы?
Напишите нам и мы свяжемся с вами в течение ближайшего времени и ответим на все интересующие вопросы